Literature DB >> 21381913

From lead management to implanted patient management: indications to lead extraction in pacemaker and cardioverter-defibrillator systems.

Igor Diemberger1, Mauro Biffi, Cristian Martignani, Giuseppe Boriani.   

Abstract

Based on the published results primarily from cohort studies, percutaneous lead extraction is now considered a safe procedure and indications for its use have broadened from device-related infections to less strict indications, such as recurrent isolated bacteremia, asymptomatic upper vein occlusion and malfunctioning/redundant leads. Almost 50% of electrophysiologists consider lead extraction in these latter situations. To broaden its implementation, further prospective evaluation against conservative approaches is still needed. Rather than only aiming at short-term results, this technique should be integrated into wide-ranging tailored long-term strategies to manage all of the different issues of implanted patients.
© 2011 Expert Reviews Ltd

Entities:  

Mesh:

Year:  2011        PMID: 21381913     DOI: 10.1586/erd.10.80

Source DB:  PubMed          Journal:  Expert Rev Med Devices        ISSN: 1743-4440            Impact factor:   3.166


  6 in total

1.  Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society.

Authors:  Giuseppe Boriani; Irina Savelieva; Gheorghe-Andrei Dan; Jean Claude Deharo; Charles Ferro; Carsten W Israel; Deirdre A Lane; Gaetano La Manna; Joseph Morton; Angel Moya Mitjans; Marc A Vos; Mintu P Turakhia; Gregory Y H Lip
Journal:  Europace       Date:  2015-06-24       Impact factor: 5.214

2.  Percutaneous lead extraction for patients with large vegetations using an unusual technique.

Authors:  Nobuhiro Nishii; Akihito Miyoshi; Yoshimasa Morimoto; Hiroshi Morita; Shingo Kasahara; Hiroshi Ito
Journal:  HeartRhythm Case Rep       Date:  2018-10-24

3.  Prognosis after lead extraction in patients with cardiac implantable electronic devices infection: Comparison of lead-related infective endocarditis with pocket infection in a Japanese single-center experience.

Authors:  Nobuhiro Nishii; Yoshimasa Morimoto; Akihito Miyoshi; Saori Tsukuda; Masakazu Miyamoto; Satoshi Kawada; Koji Nakagawa; Atsuyuki Watanabe; Kazufumi Nakamura; Hiroshi Morita; Hiroshi Morimatsu; Nobuchika Kusano; Shingo Kasahara; Morio Shoda; Hiroshi Ito
Journal:  J Arrhythm       Date:  2019-06-28

4.  Favorable Trend of Implantable Cardioverter-Defibrillator Service Life in a Large Single-Nation Population: Insights From 10-Year Analysis of the Italian Implantable Cardioverter-Defibrillator Registry.

Authors:  Stefano Poli; Giuseppe Boriani; Massimo Zecchin; Domenico Facchin; Maurizio Gasparini; Maurizio Landolina; Renato Pietro Ricci; Corrado Lanera; Dario Gregori; Alessandro Proclemer
Journal:  J Am Heart Assoc       Date:  2019-07-25       Impact factor: 5.501

5.  Implantable defibrillator lead extraction with optimized standard extraction techniques.

Authors:  Xian-Ming Chu; Xue-Bin Li; Ping Zhang; Yi An; Jiang-Bo Duan; Long Wang; Ding Li; Bing Li; Ji-Hong Guo
Journal:  J Geriatr Cardiol       Date:  2013-03       Impact factor: 3.327

6.  Incidence and Predictors of Infections and All-Cause Death in Patients with Cardiac Implantable Electronic Devices: The Italian Nationwide RI-AIAC Registry.

Authors:  Giuseppe Boriani; Marco Proietti; Matteo Bertini; Igor Diemberger; Pietro Palmisano; Stefano Baccarini; Francesco Biscione; Nicola Bottoni; Antonio Ciccaglioni; Alessandro Dal Monte; Franco Alberto Ferrari; Saverio Iacopino; Marcello Piacenti; Daniele Porcelli; Stefano Sangiorgio; Luca Santini; Michele Malagù; Giuseppe Stabile; Jacopo Francesco Imberti; Davide Caruso; Massimo Zoni-Berisso; Roberto De Ponti; Renato Pietro Ricci
Journal:  J Pers Med       Date:  2022-01-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.